Loading clinical trials...

Gastroenteritis in Pediatric Population of Qatar | Clinical Trials | Clareo Health

UNKNOWN

Gastroenteritis in Pediatric Population of Qatar

Epidemiology of Acute Gastroenteritis in the Pediatric Population in Qatar: Causes, Risk Factors, Burden of Disease, Sources and Preventable Measures

NCT03046342•Hamad Medical Corporation

View on ClinicalTrials.gov

Summary

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Detailed Description

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Eligibility

Age

0 - 14 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever

Exclusion Criteria

•1. Cases of vomiting +/- fever only without diarrhea
•2. Suspicion of surgical abdomen
•3. Bile stained vomitus
•4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency
•5. Cases of Inflammatory bowel disease
•6. Antibiotic associated diarrhea
•7. Patients with immune deficiency
•8. Patients with chronic diarrhea (\>2 weeks of diarrhea)
•9. Patients receiving long term medication for any disease

Locations (1)

Hamad medical corporation

Doha, Qatar

Key Dates

Start Date

March 10, 2015

Primary Completion Date

September 10, 2024

Completion Date

December 10, 2024

Last Updated

March 22, 2024

Enrollment

3,000

ESTIMATED participants

Conditions

Gastroenteritis

Interventions

Molecular method (PCR)

DIAGNOSTIC_TEST

Contacts

Dr.Khalid Alansari

CONTACT

+974 55336166 kalansari1@hamad.qa

Eosinophilic Gastrointestinal Disorders Registry

NCT05199532

Eosinophilic EsophagitisEosinophilic Gastroenteritis+2 more

View study

ACTIVE_NOT_RECRUITING

Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada

NCT06579170

GastroenteritisGastrointestinal Diseases+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Gastroenteritis in Pediatric Population of Qatar

Inclusion Criteria

Exclusion Criteria

Eosinophilic Gastrointestinal Disorders Registry

Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada

Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children

Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children

A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants

Examining the Effect of Ondansetron on Bowel Prep Success